These scientists created a model city to figure out the most effective order to give the vaccine

Different strategies reduce total cases, reduce total deaths, or end lockdowns sooner.

New Rochelle, a city of 80,000 people in upstate New York, was one of the earliest COVID-19 hot spots in the country. In early March last year, it experienced a serious outbreak even before nearby New York City became the initial epicenter of the virus.

Read Full Story

Related Articles

A startup that's taking on Big Pharma just raised $500 million

Summary List PlacementHello, 
Today in healthcare news: EQRx has raised another $500 million, at least 50% of COVID-19 cases spread from people without symptoms, and some evidence that Pfizer’s vaccine works against virus mutations. 

EQRx, a startup that’s taking on Big Pharma by making drugs cheaper, just raised $500 million

EQRx, a company developing new drugs that’ll compete with some of the highest-priced drugs on the market at a lower price, is moving faster than it expected.
A year in, the startup just raised a fresh $500 million from investors including GV, Andreessen Horowitz, and Arch Venture Partners, as well as from private equity funds, health plans and health systems.
It aims to get have its first treatment approved in the next “handful of years” and has brought on four cancer drugs that are in later stages of development. 

Read the full story here > >

At least 50% of COVID-19 cases spread from people without symptoms, a new study found

At least 50% of new COVID-19 cases are transmitted by people who don’t show symptoms, according to a new study.
That includes people who never display symptoms and those whose symptoms hadn’t started yet.
A study authors said findings underscore the need for people who feel healthy to follow public-health guidance on mask wearing and social distancing.

Read the full story from Susie Neilson here > >

Early study suggests Pfizer’s vaccine is effective against coronavirus mutations

A study by Pfizer and researchers at the University of Texas Medical Branch indicates the company’s COVID-19 vaccine is effective against mutations of the coronavirus.
The study has not yet been peer-reviewed.
“So we’ve now tested 16 different mutations, and none of them have really had any significant impact. That’s the good news,” Phil Dormitzer, a scientist at Pfizer, said Thursday. “That doesn’t mean that the 17th won’t,” he added.

Read the full story from Charles Davis here > >

More stories we’re reading: 

How West Virginia is winning the race to get COVID-19 vaccines into people’s arms, including using its own pharmacies (NPR)
Biden plans to release the entire coronavirus vaccine supply instead of reserving half to guarantee second doses (Business Insider)
LA is facing its “New York Moment” as the virus overwhelms the largest county in the US (The New York Times)
I felt totally fine after my first COVID-19 shot, but the second dose was rough. Here’s what I did to manage the side effects and why I still think you should get the shot. (Business Insider)

– LydiaJoin the conversation about this story » NOW WATCH: A cardiologist revealed the truth behind red wine’s health benefits

How to build the city of the future, according to Ikea’s innovation lab

‘The Ideal City’ collects the most successful urban ideas from around the world, to serve as a sort of cookbook of best practices for city leaders.

By the end of the century, if cities continue to grow at current rates, the world’s urban space may expand by 618,000 square miles—the equivalent of building another city the size of Manhattan nearly every day for the next 78-plus years.Read Full Story

Some VCs are saying San Francisco is over. Now they have the numbers to back that up.

Summary List PlacementSome VCs have been declaring that San Francisco is over, and now they have the numbers to prove it.
Despite record-breaking investment in the venture capital industry, the Bay Area saw a sharp decline in angel and seed deals in 2020, according to a report by Pitchbook and the National Venture Capital Association.
In 2020, San Francisco reached only 81.2% of the angel and seed deals it made in 2019. Although it still had more deals than any other city, it recorded a “a 10-year low in proportion of total deal count.” This means, compared to other major cities, San Francisco was less dominant than it’s been in the last decade.
It’s easy to attribute this to the pandemic; however, the venture capital industry managed to invest over $150 billion this year for the first time ever. VCs weren’t necessarily investing less — this newly-remote world just gave other cities a better chance to get in on the action. 
Read more: Venture capital had a record-breaking 2020: $150 billion in deals, all-time highs for fundraising and results
This could be a told-you-so moment for VCs who have been championing an end to Silicon Valley’s dominance in the startup world. 
Founders Fund general partner Keith Rabois has been vocal about his move to Miami, insisting other VCs are doing the same.  
“There are lots of people that have already moved that haven’t been written about that are pretty high profile,” Rabois told Insider, although he declined to say who. “Post-COVID, I think the concentration of talent has atrophied, perhaps permanently.”
Similarly, prominent VCs like Palantir co-founder Joe Lonsdale left San Francisco and Opendoor co-founder J.D. Ross left the Bay Area for Austin, among a long list of other tech elites who went to other cities. Investors have cited San Francisco’s taxes, tiny apartments, and homelessness issue as reasons for their departure.
Of course, Silicon Valley has been pronounced dead before, and it’s managed to come back swinging. The city has been subject to many tech booms and busts over the decades and the pandemic may have simply ushered in another bust cycle.
“Everyone either thinks San Francisco is the center of the universe or it’s dead,” venture capitalist Ann Miura-Ko told tech journalist Eric Newcomer in his newsletter. “It’s just super annoying because anyone who has been here for over one cycle knows it always comes back and it always also falls out of favor.”
It’s also worth noting the majority of deals were still made in the Bay Area, with a total of 2,503 completed deals. This was miles ahead of second place: the New York area with 1,500 deals. 
Read more: VC Elizabeth Yin says investors are really driven by a ‘hype market’ and if founders use it, they will raise more money at higher valuations
A remote world, however, has certainly given other areas of the country a chance to thrive. Atlanta saw a 13.1% increase in angel and seed deals over 2019, completing nearly 100 angel and seed deals for the first time in over half a decade. Atlanta has been up-and-coming for awhile, landing at number eight on our list of cities outside of Silicon Valley to start your business, and launching startups like MailChimp and Kabbage.
Boston was the only other major city to show an increase in deals. Meanwhile, New York City, Chicago, and Los Angeles all experienced a decrease in deals — albeit not as drastic a drop as San Francisco. 
Still, the report said we may be seeing the start of a long-term trend away from the Bay Area for startups, heralding 2020 as a “harbinger for investment trends to shift further outside of the region’s venture hub.” 

Now read:
MeWe doesn’t want to be the next Parler. But extremist hordes are coming to the social-media site anyway.
Plaid investors say they are happy the government killed its $5.3 billion sale: ‘While we had a bird in hand with Visa, a little patience will really pay off’
Join the conversation about this story » NOW WATCH: Why thoroughbred horse semen is the world’s most expensive liquid

Responses

Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about chronicles from TreatMyBrand directly in your inbox